B Braun buys $63m parenterals firm for Asian growth
This article was originally published in Clinica
Executive Summary
B Braun, a leading player in medical devices, critical care, surgical instruments and renal care therapy, has acquired 75% of Ahlcon Parenterals, as part of the German multinational's strategy to accelerate growth in India and other markets in the region.